These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 22829202

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Apricoxib upregulates 15-PGDH and PGT in tobacco-related epithelial malignancies.
    St John MA, Wang G, Luo J, Dohadwala M, Hu D, Lin Y, Dennis M, Lee JM, Elashoff D, Lawhon T, Zaknoen SL, Burrows FJ, Dubinett SM.
    Br J Cancer; 2012 Aug 07; 107(4):707-12. PubMed ID: 22828609
    [Abstract] [Full Text] [Related]

  • 6. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
    Lu YY, Jing DD, Xu M, Wu K, Wang XP.
    World J Gastroenterol; 2008 Sep 21; 14(35):5403-11. PubMed ID: 18803351
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts.
    Wang X, Zhang L, O'Neill A, Bahamon B, Alsop DC, Mier JW, Goldberg SN, Signoretti S, Atkins MB, Wood CG, Bhatt RS.
    Br J Cancer; 2013 Feb 05; 108(2):319-26. PubMed ID: 23322198
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors.
    Ding N, Cui XX, Gao Z, Huang H, Wei X, Du Z, Lin Y, Shih WJ, Rabson AB, Conney AH, Hu C, Zheng X.
    Int J Oncol; 2014 Jun 05; 44(6):2139-45. PubMed ID: 24647860
    [Abstract] [Full Text] [Related]

  • 12. The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.
    Dineen SP, Sullivan LA, Beck AW, Miller AF, Carbon JG, Mamluk R, Wong H, Brekken RA.
    BMC Cancer; 2008 Nov 27; 8():352. PubMed ID: 19038046
    [Abstract] [Full Text] [Related]

  • 13. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L, Chen W, Xie X, He Y, Bai X.
    Exp Oncol; 2008 Mar 27; 30(1):42-51. PubMed ID: 18438340
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synergistic effect between erlotinib and MEK inhibitors in KRAS wild-type human pancreatic cancer cells.
    Diep CH, Munoz RM, Choudhary A, Von Hoff DD, Han H.
    Clin Cancer Res; 2011 May 01; 17(9):2744-56. PubMed ID: 21385921
    [Abstract] [Full Text] [Related]

  • 18. Combined inhibition of epidermal growth factor receptor and cyclooxygenase-2 leads to greater anti-tumor activity of docetaxel in advanced prostate cancer.
    Lin J, Wu H, Shi H, Pan W, Yu H, Zhu J.
    PLoS One; 2013 May 01; 8(10):e76169. PubMed ID: 24155892
    [Abstract] [Full Text] [Related]

  • 19. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF.
    Ma JX, Sun YL, Wang YQ, Wu HY, Jin J, Yu XF.
    Oncol Res; 2013 May 01; 20(8):359-68. PubMed ID: 23924856
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of GEP100 Improved the Growth Inhibition Effect of Erlotinib Through Modulating Mesenchymal Epithelial Transition Process in Pancreatic Cancer.
    Xie CG, Sun SL, Wei SM, Xu XM, Shao LM, Chen JM, Cai JT.
    Pancreas; 2018 Jul 01; 47(6):732-737. PubMed ID: 29851753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.